1. Home
  2. NTRA vs DRI Comparison

NTRA vs DRI Comparison

Compare NTRA & DRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$204.80

Market Cap

28.0B

Sector

Health Care

ML Signal

HOLD

Logo Darden Restaurants Inc.

DRI

Darden Restaurants Inc.

HOLD

Current Price

$195.85

Market Cap

25.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
DRI
Founded
2003
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
28.0B
25.1B
IPO Year
2015
2000

Fundamental Metrics

Financial Performance
Metric
NTRA
DRI
Price
$204.80
$195.85
Analyst Decision
Strong Buy
Buy
Analyst Count
14
25
Target Price
$259.07
$226.50
AVG Volume (30 Days)
1.1M
1.4M
Earning Date
05-07-2026
03-19-2026
Dividend Yield
N/A
3.06%
EPS Growth
0.65
4.11
EPS
N/A
6.87
Revenue
$210,939,000.00
$12,076,700,000.00
Revenue This Year
$18.16
$10.10
Revenue Next Year
$20.00
$3.84
P/E Ratio
N/A
$28.58
Revenue Growth
N/A
6.03
52 Week Low
$130.29
$169.00
52 Week High
$256.36
$228.27

Technical Indicators

Market Signals
Indicator
NTRA
DRI
Relative Strength Index (RSI) 53.10 43.74
Support Level $194.03 $182.65
Resistance Level $251.09 $212.97
Average True Range (ATR) 7.50 6.20
MACD 2.09 -0.37
Stochastic Oscillator 80.56 28.28

Price Performance

Historical Comparison
NTRA
DRI

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About DRI Darden Restaurants Inc.

Darden Restaurants is the largest restaurant operator in the US full-service space, with consolidated revenue of $12.1 billion in fiscal 2025. The company maintains a portfolio of 11 restaurant brands: Olive Garden, LongHorn Steakhouse, Cheddar's Scratch Kitchen, Ruth's Chris Steak House, Yard House, The Capital Grille, Seasons 52, Eddie V's, Bahama Breeze, The Capital Burger, and Chuy's. Darden generates revenue almost exclusively from company-owned restaurants, though a small network of franchised restaurants and consumer-packaged goods sales through the traditional grocery channel contribute modestly. At the end of fiscal 2025, the company operated 2,159 restaurants in the US.

Share on Social Networks: